, the -founded brain implant startup, on Monday officially a $650 million Series E funding round, confirming earlier reports that the Fremont, California-based company was set to close on a massive raise.
The raise, which values Neuralink at $9 billion, is by far the largest for a startup working on brain-computer interface technology, but comes as funding to neuroscience startups overall is set to rise sharply this year. All told, funding to the broader category of neuroscience startups totaled $896 million last year and is on track to reach $1.4 billion in 2025, data shows.
Neuralink has now raised a total of $1.3 billion since its founding in 2016, data shows. It received its latest backing from , , , , , , , , , and , among others.
Its brain implants are designed to treat neurological disorders such as paralysis and blindness. The company said five people with “severe paralysis” are now using Neuralink technology “to control digital and physical devices with their thoughts, marking a profound step toward helping restore independence.”
The company’s brain implant device, which has a chip that processes neural signals that can be transmitted to computers or phones, is .
While Neuralink is the most well-funded of the group, other companies working on computer-brain interfaces have also raised significant venture backing, a review of data shows.
To illustrate, we put together a curated list of some of the most well-funded companies in the space.
They include ., which says it’s developing devices “aimed at restoring vision, cognition, and mobility to patients who have lost it.” The Alameda, California-based company announced in April that it had in a round led by . (The financing was in the form of a convertible note, according to data). The company has since its 2021 inception. Besides Khosla, investors include , and, among others.
Another example is China’s , a Neuralink competitor that raised a $48 million Series B funding round in February, the largest-ever funding round for a startup in the field in that country. It’s unclear how much the company raised in previous venture rounds.
Meanwhile, another Neuralink competitor, Austin, Texas-based , announced on June 1 that it had performed its using its Connexus Brain-Computer Interface. Paradromics has in funding since its 2015 inception, according to data. Investors include , , , and.
Related list:
Illustration:

Stay up to date with recent funding rounds, acquisitions, and more with the Daily.
67.1K Followers